VIA
PRAX icon

Virtus Investment Advisers’s Praxis Precision Medicines PRAX Stock Holding History

Virtus Investment Advisers’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
1,227
+214
+21% +$67.7K 0.1% 258
2026
Q1 		$326K Buy
1,013
+24
+2% +$7.42K 0.09% 266
2025
Q4 		$291K Sell
989
-1,538
-61% -$286K 0.08% 261
2025
Q3 		$134K Buy
2,527
+439
+21% +$21.3K 0.04% 395
2025
Q2 		$87.8K Sell
2,088
-228
-10% -$8.68K 0.03% 392
2025
Q1 		$87.7K Buy
+2,316
New +$145K 0.02% 438

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Virtus Investment Advisers's PRAX Position: Q2 2026 in Review

Virtus Investment Advisers increased its Praxis Precision Medicines (PRAX) stake by 21% in Q2 2026, buying an estimated $67.7K and bringing the position to 1,227 shares worth $411K. The position accounts for 0.1% of the portfolio, ranked #258.

Virtus Investment Advisers first reported a position in PRAX in Q1 2025 and has held it in 6 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Virtus Investment Advisers held 1,227 shares of Praxis Precision Medicines worth $411K as of Q2 2026.
  • Virtus Investment Advisers bought 214 Praxis Precision Medicines shares in Q2 2026, an estimated $67.7K.
  • Praxis Precision Medicines made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #258 holding.
  • Virtus Investment Advisers first reported a position in Praxis Precision Medicines in Q1 2025 and has held it in 6 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.